Co-morbidities of vertiginous diseases

Vertigo and dizziness are, after headache and back pain, the most common symptoms in daily clinical practice. The prevalence of vertigo is age depending and is in the range within 17 and 39% [1]. Vertigo is frequently noted as symptoms of other neurological, cardiovascular, haematological, and infectious diseases, and as adverse reactions to medical treatment. Otherwise it is not always easy to differentiate if these diseases are the cause of vertigo syndrome or to be seen as a co-morbidity of the vertigo syndrome. It is also not known that these co-morbidities have an influence on the prognosis of the main disorder. The aim of our study was to detect co-morbidities in vertiginous diseases in general and in a subgroup with clearly defined vertigo syndromes in particular. Therefore we analysed a sample of our patients who were seen in our outpatient clinic. The outpatient clinic is a tertiary centre for patients with vertigo and dizziness. In the majority of cases these patients suffer from chronic vertigo and presented themselves after several consultations with medical specialists per referral at our outpatient clinic. Some of the most frequent vertiginous diseases diagnosed in our outpatient clinic [2] were examined in detail: postural phobic vertigo (PPV), benign paroxysmal positional vertigo (BPPV), Meniere's disease (MD) and vestibular migraine (VM).

In total, 131 patients corresponded to the criteria of our trial and completed the questionnaire. The mean age was 54.0 years, 57.3% were female. Fifty-three patients (40.5%) in this cohort were diagnosed with PPV, 19 patients (14.5%) had BPPV, 11 patients (8.4%) had MD and 14 patients (10.7%) were classified as VM.

With regard to the co-morbidities arterial hypertension, diabetes mellitus, headache, migraine, and psychiatric diseases reported by the patients, we noted one co-morbidity in 49 patients (37.4%), two co-morbidities in 27 patients (20.6%) and three co-morbidities in eight patients (6.1%) of the cohort.

The aim of our study was the evaluation of co-morbidities in a group of patients with vertiginous diseases. We did not investigate the prevalence of the different vertiginous diseases in the general population since we included only patients screened in our specialized outpatient clinic. We made sure that the patients who were not included in the study due to missing data had nearly the same mixture of diagnosis as the study population. It is therefore unlikely that this biased the seen co-morbidities.

In comparison to the data of a national telephone health survey in Germany [5], the prevalence of hypertension in our cohort (29.0%) reached a marginally higher percentage than in the general population (27.1%). From this, we can infer that there was no distinctive feature in the prevalence of hypertension in patients with a vertiginous disease in our study. In comparison to other studies with vertigo patients, we could not find a relationship between BPPV and hypertension [6], which may be due to a lack of statistical power in this subgroup.

The prevalence of diabetes mellitus in Germany is approximately 5% to 7% of the general population [7]; we detected a similar prevalence in our trial (6.1%). Moreover, with a prevalence of 6.1% in our trial, we confirmed the findings of a previous study [8] that there is no elevated co-morbidity of diabetes mellitus and a vertiginous disease, especially if we consider that the patients in the study were on average older than the general population and that the prevalence of diabetes is strongly dependent on age. The median age in our cohort diagnosed with vertigo was 54.0 years and therefore slightly higher than in the population-based survey explaining the small differences in prevalence of diabetes mellitus.

Comparative data from a national survey [9] indicated that in the age group 50 to 59 years, 40.2% were overweight and 23.0% were obese. In contrast, 33.6% of the patients in our study were overweight and only 13.7% were obese. Furthermore, we did not find elevated prevalences of obesity and higher BMI among this cohort of vertigo patients, in contrast to previously published results on the prevalence of chronic headache and BMI [10].

Based on the data of a national survey [11], the prevalence of any headache is approximately 69% in women and 53% in men. The prevalence of headache (except migraine) in our study was 36.6% and therefore significantly lower than in the general population. The patients with PPV showed a marginally (relative risk: 1.25) but not significantly higher prevalence of headaches than the other patients from the cohort.

For the whole sample of patients with vertigo there was no increased prevalence of migraine in our study (9.4%) compared to a recent epidemiological study that observed a 6-month prevalence of 11.2% for migraine [12]. We excluded the patients with VM from this analysis since per definition the prevalence of migraine in these patients has to be 100%.

The most interesting finding was concerning the prevalence of psychiatric diseases assed with the ADS-L questionnaire, an evaluated and often used questionnaire. We found a significantly increased prevalence of psychiatric diseases in patients with PPV (p = 0.014) compared to the other main diagnoses. In comparing the prevalence in co-morbidities, we included all psychiatric disorders from the ICD-10 Chapter V (F) including depression. Not every patient with PPV suffered from other psychiatric disorders, supporting the concept of PPV as a separate entity and not only as a symptom of a more general psychiatric disorder. However, the assumed prevalence of psychiatric disorders in patients with PPV was in line with the one-year-prevalence of psychiatric diseases in Europe [13]. In comparison, a study about the prevalence of affective diseases in upper Bavaria revealed only a prevalence of 6.8% for affective diseases like depression [14].

Furthermore, 19.2% of the patients with PPV and more than 10% of the patients with BPPV and MD and 21.4% of the patients with VM scored 30 points or more in the ADS-L, which indicates a strong clinical suspicion of a manifest depression. The group of PPV patients and the patients with VM had a slightly but not significantly increased relative risk (1.26 and 1.32) of suffering from a manifest depression. Referring to this we cannot rule out a connection between depression and chronic vertigo and vice versa. With respect to data of another vertigo trial [15], our cohort showed approximately the same prevalence for a clinical relevant depression. In contrast, the prevalence of depression in our study cohort was significantly lower than in trials with patients suffering from tension-type headache [16, 17] and migraine [16, 18]. In a comparative study with patients diagnosed with diabetes mellitus, 22.0% scored 16 or more in the CES-D [19]. Another study, which evaluated the outcome 100 days after an ischemic stroke, showed a CES-D-cut-off for depression (10 points) in 32.9% [20], equivalent to a score of 20 points or more in the ADS-L, which 40.7% of the patients in our study achieved. In contrast, a study with patients suffering from chronic pain, reported an average CES-D of 24.0, which exceeds the average score of 19.2 in our study [21]. The prevalence of depression in vertigo is comparable to the prevalence of depression in other chronic diseases.

Limitations of the study are that due to the number of cases the study did not allow for an analysis stratified by gender and age. It further should be mentioned that the participants in our study are patients from a tertiary centre specializing in vertiginous disease, which is likely to result in an over- or underrepresentation of certain vertiginous diseases (e.g. higher prevalence of PPV) and we therefore limited our analysis on the examination of the co-morbidities in vertiginous diseases.

In conclusion, we found a higher prevalence of psychiatric co-morbidities, such as depression in the PPV patients, as well as a higher prevalence of hypertension in patients with MD. Otherwise there was no elevated prevalence of hypertension, diabetes mellitus, general headaches and migraine as well as obesity in comparison to general population. Further studies with larger numbers of patients need to be performed to give additional support to our findings.